Editorial: Deprescribing and Minimizing Use of Anticholinergic Medications
dc.contributor.author | Soiza, Roy L. | |
dc.contributor.author | Boustani, Malaz A. | |
dc.contributor.author | Campbell, Noll L. | |
dc.contributor.author | Mangoni, Arduino A. | |
dc.contributor.department | Medicine, School of Medicine | |
dc.date.accessioned | 2024-10-24T13:53:22Z | |
dc.date.available | 2024-10-24T13:53:22Z | |
dc.date.issued | 2021-12-15 | |
dc.eprint.version | Final published version | |
dc.identifier.citation | Soiza RL, Boustani MA, Campbell NL, Mangoni AA. Editorial: Deprescribing and Minimizing Use of Anticholinergic Medications. Front Pharmacol. 2021;12:820051. Published 2021 Dec 15. doi:10.3389/fphar.2021.820051 | |
dc.identifier.uri | https://hdl.handle.net/1805/44206 | |
dc.language.iso | en_US | |
dc.publisher | Frontiers Media | |
dc.relation.isversionof | 10.3389/fphar.2021.820051 | |
dc.relation.journal | Frontiers in Pharmacology | |
dc.rights | Attribution 4.0 International | en |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
dc.source | PMC | |
dc.subject | Anticholinergic | |
dc.subject | Antimuscarinic | |
dc.subject | Drug safety | |
dc.subject | Medication withdrawal | |
dc.subject | Medicines optimisation | |
dc.subject | Prescribing | |
dc.title | Editorial: Deprescribing and Minimizing Use of Anticholinergic Medications | |
dc.type | Article |